Literature DB >> 7882568

Antigen-presenting cells in human cutaneous leishmaniasis due to Leishmania major.

A M ElHassan1, A Gaafar, T G Theander.   

Abstract

In this study biopsies from skin lesions and draining lymph nodes of patients suffering from cutaneous leishmaniasis caused by Leishmania major were examined by immunohistochemistry, and by light and electron microscopy to identify the types of antigen-presenting cells (APC) and their location. APC, identified morphologically and by their expression of specific cell markers, included Langerhans cells, macrophages, follicular dendritic cells, and interdigitating reticulum cells of the paracortex of lymph nodes. These cells expressed MHC class II antigens and contained Leishmania antigen. Since some keratinocytes and endothelial cells also showed these characteristics, they may also act as APC. By examining tissue samples from skin lesions and draining lymph nodes it was possible to follow the probable route of trafficking of various inflammatory cells between the skin lesion and lymph nodes. Leishmania antigen containing Langerhans cells were found in the epidermis, dermis and the regional lymph nodes. We believe these cells translocate from the epidermis to the dermis, where they take up antigen and migrate to the paracortex of the regional lymph nodes. There they are intimately associated with cells of the paracortex, and could be involved in the generation of Leishmania-specific T memory cells. LFA-1-positive T cells of the CD45RO phenotype were found in the skin lesion. Venular endothelium in the skin lesions expressed intercellular adhesion molecule-1 (ICAM-1), which is the ligand for LFA-1. The migration of lymphocytes from the vascular lumen to the site of inflammation is possibly a result of the interaction of these two adhesion molecules.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7882568      PMCID: PMC1534205          DOI: 10.1111/j.1365-2249.1995.tb05571.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Enriched epidermal Langerhans cells are potent antigen-presenting cells for T cells.

Authors:  S Bjercke; J Elgø; L Braathen; E Thorsby
Journal:  J Invest Dermatol       Date:  1984-10       Impact factor: 8.551

2.  Anti-Leu-3/T4 antibodies react with cells of monocyte/macrophage and Langerhans lineage.

Authors:  G S Wood; N L Warner; R A Warnke
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

3.  A histological classification of cutaneous leishmaniasis and its geographical expression.

Authors:  D S Ridley
Journal:  Trans R Soc Trop Med Hyg       Date:  1980       Impact factor: 2.184

4.  Cutaneous leishmaniasis: immune complex formation and necrosis in the acute phase.

Authors:  M J Ridley; D S Ridley
Journal:  Br J Exp Pathol       Date:  1984-06

5.  The ultrastructural morphology of human cutaneous leishmaniasis of low parasite load.

Authors:  A M el Hassan; B Veress; M K Kutty
Journal:  Acta Derm Venereol       Date:  1984       Impact factor: 4.437

6.  Induction by specific T lymphocytes of intracellular destruction of Leishmania major in infected murine macrophages.

Authors:  S G Coutinho; J A Louis; J Mauel; H D Engers
Journal:  Parasite Immunol       Date:  1984-03       Impact factor: 2.280

7.  Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry.

Authors:  S M Hsu; E Soban
Journal:  J Histochem Cytochem       Date:  1982-10       Impact factor: 2.479

8.  The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes.

Authors:  W C Van Voorhis; G Kaplan; E N Sarno; M A Horwitz; R M Steinman; W R Levis; N Nogueira; L S Hair; C R Gattass; B A Arrick; Z A Cohn
Journal:  N Engl J Med       Date:  1982-12-23       Impact factor: 91.245

9.  Macrophage activation to kill Leishmania major: activation of macrophages for intracellular destruction of amastigotes can be induced by both recombinant interferon-gamma and non-interferon lymphokines.

Authors:  C A Nacy; A H Fortier; M S Meltzer; N A Buchmeier; R D Schreiber
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

10.  Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis.

Authors:  M Kemp; A S Hey; J A Kurtzhals; C B Christensen; A Gaafar; M D Mustafa; A A Kordofani; A Ismail; A Kharazmi; T G Theander
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

View more
  8 in total

1.  Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis.

Authors:  V Yardley; S L Croft
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

2.  Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity.

Authors:  K Maasho; F Sanchez; E Schurr; A Hailu; H Akuffo
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  The skin homing receptor cutaneous leucocyte-associated antigen (CLA) is up-regulated by Leishmania antigens in T lymphocytes during active cutaneous leishmaniasis.

Authors:  C de O Mendes-Aguiar; A Gomes-Silva; E Nunes; R Pereira-Carvalho; R S Nogueira; M de P Oliveira-Neto; A L Bertho; A M Da-Cruz
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

4.  Induction and abrogation of LACK reactive cells in the evolution of human leishmaniasis.

Authors:  K Maasho; D Wolday; M Edjigu; K Söderström; S Britton; H Akuffo
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

5.  Imaging Leishmania major Antigens in Experimentally Infected Macrophages and Dermal Scrapings from Cutaneous Leishmaniasis Lesions in Tunisia.

Authors:  Nasreddine Saïdi; Yousr Galaï; Meriem Ben-Abid; Thouraya Boussoffara; Ines Ben-Sghaier; Karim Aoun; Aïda Bouratbine
Journal:  Microorganisms       Date:  2022-06-04

6.  The role of vascular endothelium and exosomes in human protozoan parasitic diseases.

Authors:  Sanjay Varikuti; Bijay Kumar Jha; Erin A Holcomb; Jodi C McDaniel; Manjula Karpurapu; Nidhi Srivastava; Bradford S McGwire; Abhay R Satoskar; Narasimham L Parinandi
Journal:  Vessel Plus       Date:  2020-09-27

7.  FasL and TRAIL signaling in the skin during cutaneous leishmaniasis - implications for tissue immunopathology and infectious control.

Authors:  Bence Rethi; Liv Eidsmo
Journal:  Front Immunol       Date:  2012-06-19       Impact factor: 7.561

8.  Meta-transcriptome Profiling of the Human-Leishmania braziliensis Cutaneous Lesion.

Authors:  Stephen M Christensen; Laura A L Dillon; Lucas P Carvalho; Sara Passos; Fernanda O Novais; V Keith Hughitt; Daniel P Beiting; Edgar M Carvalho; Phillip Scott; Najib M El-Sayed; David M Mosser
Journal:  PLoS Negl Trop Dis       Date:  2016-09-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.